StockWatch
·
Pharmaceuticals
Board Meeting9 Nov 2026, 11:10 pm

Everest Organics Board Meeting on Nov 12, 2026

AI Summary

Everest Organics Limited has announced that its Board of Directors will convene on Thursday, November 12, 2026. The primary agenda item is to consider and approve the Unaudited Financial Results (Standalone) for the quarter and half-year ended September 30, 2026, along with the Limited Review Report from the Statutory Auditors. Concurrently, the trading window for designated persons and their immediate relatives has been closed from October 1, 2026, and will reopen 48 hours after the declaration of these financial results.

Key Highlights

  • Board meeting scheduled for November 12, 2026.
  • To consider unaudited financial results for Q2 FY27.
  • Limited Review Report to be approved.
  • Trading window closed for designated persons.